Posts filtered by tags: Hepatitis C[x]


Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More

Generic drugs are supposed to give consumers more choices and a counterweight to more costly branded medications. During his tenure as FDA commissioner, Scott Gottlieb often spoke about generics as a market force that could help tame climbing drug prices. But such tools only work when companies play fair.A lawsuit is now claiming that many top generic drug makers routinely conspired to avoid competition. In a more than filed in federal court in Connecticut, 44 states allege that 18 generic dr...
Tags: Deals, Startups, Lawsuit, Breast Cancer, Drugs, Cancer, Trends, Investing, Hypertension, Connecticut, Venture Capital, Private Equity, Fda, National, Biotech, Cystic Fibrosis

Vertex Continues Plan to Diversify, Strikes a $70M Pact With Kymera

Vertex Pharmaceuticals is best known for its cystic fibrosis franchise. But over the past several years Vertex has been making inroads elsewhere, and a deal it is announcing this morning continues that strategy.Vertex (NASDAQ: VRTX), of Boston, will pay privately held startup Kymera Therapeutics $70 million to form an alliance to develop a group of drugs for “serious specialty diseases.” Vertex won’t say which ones, but beyond cystic fibrosis (CF), where it has three FDA-approved drugs that gen...
Tags: Deals, Startups, Boston, Trends, Vc, Fda, GlaxoSmithKline, Biotech, Pain, Cystic Fibrosis, Life Sciences, CRISPR Therapeutics, Vertex, Merck KGaA, Hepatitis C, Vertex Pharmaceuticals

Infected blood may have been given after safe date, inquiry hears

Testimony raises questions about assurances provided on screening out of hepatitis CContaminated blood may have been given to NHS patients after the date when transfusions were supposed to have screened out hepatitis C, the infected blood inquiry has been told.Testimony from a woman who believes she contracted the disease during treatment for cancer in 1992 also revealed how blood batch numbers had been mistranscribed in health service records, making it impossible to trace donors. Continue read...
Tags: Health, Society, UK News, NHS, Hepatitis C, Contaminated blood scandal

Infected blood victim recalls moment he found out he was HIV positive - video

The first day of the long-awaited infected blood inquiry has heard from several victims about the devastating impact it had on their lives. Derek Martindale was 23 when he was diagnosed with HIV in 1985 and given a year to live. Martindale told the inquiry that his brother Richard, who also had severe haemophilia, contracted the virus and died aged 23 in 1990. In an emotional evidence session, he said his greatest regret was not being able to support his brother in the months before he died.Infe...
Tags: Health, NHS, Aids and HIV, Richard, Hepatitis C, Martindale, Contaminated blood scandal, Derek Martindale

'There was no future': victims share impact of infected blood scandal

Patients infected with HIV and hepatitis C give emotional evidence on first day of inquiryThe first day of the long-awaited infected blood inquiry has heard from several victims about the devastating impact it had on their lives. Here is what two of them had to say:Derek Martindale
Tags: Health, UK News, NHS, Health policy, Aids and HIV, Hepatitis C, Contaminated blood scandal

Infected blood inquiry judge calls for more testing for hepatitis C

Sir Brian Langstaff urges greater awareness of ‘terrible disease’ in opening remarksMore widespread medical testing should be carried out to detect the “terrible disease” of hepatitis C and ensure it is eliminated faster, the judge chairing the infected blood inquiry has recommended.On the first day of the main inquiry, Sir Brian Langstaff supported calls for greater public and medical awareness of the condition that has infected 180 million people worldwide. Continue reading...
Tags: Health, Society, UK News, Public services policy, NHS, Health policy, Hepatitis C, Contaminated blood scandal, Brian Langstaff

Infected blood victims call for more mass screening for hepatitis C

Government urged to test NHS patients given blood products or transfusions in 1970s-90sVictims of the NHS contaminated blood scandal have called on the government to extend mass screening for hepatitis C infections to prevent more deaths.The plea came as the prime minister, Theresa May, pledged additional financial support for those infected as well as bereaved relatives affected by the medical disaster. Continue reading...
Tags: Health, Society, UK News, Hospitals, Theresa May, NHS, Aids and HIV, Hepatitis C, Contaminated blood scandal

Gilead Sciences Commits $150M to Agenus in Cancer Drug R&D Pact

For the second time this week, Gilead Sciences has partnered with a Boston-area biotech, this time with a deal that covers up to five experimental cancer immunotherapies being developed by Agenus.Under the deal terms, Foster City, CA-based Gilead (NASDAQ: GILD) will pay Agenus (NASDAQ: AGEN) $120 million cash up front and make a $30 million equity investment in the company. Depending on the progress of the drugs, Gilead could pay its Lexington, MA, partner up to $1.7 billion more in fees and mi...
Tags: Deals, Boston, Cancer, Hiv, San Francisco, Trends, Fda, Biotech, Life Sciences, Clinical Trials, Agen, Gilead Sciences, Gilead, Hepatitis C, Kite Pharma, Lexington MA

Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More

Pharmaceutical industry critics lament the cost of rare disease drugs, but some of the steepest price hikes have come on widely used insulin.The patent holder, the University of Toronto, gave companies the right to manufacture insulin. But the university also allowed them to patent the improvements they made, which enabled them to slap higher prices on each new version.In the nearly 100 years since insulin’s discovery, no generic version has become available in the U.S. to offer competitive pri...
Tags: Deals, Startups, Breast Cancer, Washington, Ipo, Cancer, Trends, Investing, Diabetes, Schizophrenia, Venture Capital, Addiction, Fda, National, Novartis, Biotech

UC researchers recommend universal screening to tackle rise in Hepatitis C

Physicians are encountering a growing number of younger patients who are testing positive for hepatitis C virus (HCV) fueled largely by the opioid crisis impacting communities around the country. That increase and more effective and tolerable drug regimens for HCV infection, means one-time universal screening of all adults for HCV is now cost effective and recommended, say physician researchers in the University of Cincinnati (UC) College of Medicine.
Tags: Hepatitis C

HIV, hepatitis, death: infected blood scandal inquiry puts victims first

After decades of silence, victims of the infected blood scandal dare to hope for justiceEvery morning a bell was rung to announce the start of proceedings. But it may just as well have been tolling for the dead. At least 4,689 haemophiliacs were given contaminated blood products in the 1970s and 1980s, and contracted HIV and/or hepatitis C. More than half have since died. Then there are the thousands infected by blood transfusions.On the steps of Church House, next to Westminster Cathedral, grou...
Tags: Health, Japan, UK, France, America, UK News, Britain, Ireland, NHS, Aids and HIV, Church House, Hepatitis C, Westminster Cathedral, Contaminated blood scandal

'Treated like pariahs': contaminated blood victims tell their stories

Those infected or affected hope inquiry into the scandal will finally reveal the truthWalton married her husband, Bryan, in 1983. He died a “terrible, horrendous” death 10 years later having passed the HIV virus on to her. Continue reading...
Tags: Health, Society, UK News, NHS, Aids and HIV, Bryan, Hepatitis C, Hepatitis B, Contaminated blood scandal

Infected blood victims may not yet have been told why they feel ill, inquiry hears

Investigation begins into scandal thought to have killed more than 2,000 peopleThousands of victims of the contaminated blood scandal may not yet have been told the reasons why they are feeling unwell, the chair of the inquiry has said.Formally opening the infected blood inquiry, Sir Brian Langstaff said that many people may not have been diagnosed as suffering from hepatitis C, which they acquired through blood transfusions they received when they were younger.“It is a truly sobering thought,” ...
Tags: Health, Law, US, Society, NHS, Aids and HIV, Hepatitis C, Contaminated blood scandal, Brian Langstaff

'I gave birth, and got Hepatitis C'

When Jackie Britton was given a blood transfusion during childbirth, it could have killed her.
Tags: UK, News, Hepatitis C, Jackie Britton

There's a Cure for Hepatitis C, but Insurance Companies Don't Want to Pay for It

True cures in medicine are surprisingly rare. But for nearly five years, doctors have had one available for hepatitis C, an often chronic, life-shortening viral disease that wreaks havoc on the liver. The only problem, as a depressing study published Thursday in Open Forum Infectious Diseases highlights, is that…Read more...
Tags: Science, Drugs, Cure, Hepatitis C

Judge gives early OK to deal to expand Medicaid hep C relief

DETROIT (AP) — A judge has given preliminary approval to a deal that would expand access to hepatitis C treatments for Michigan residents on Medicaid. Gov. Rick Snyder’s health department was accused of limiting new antiviral medicine only to the most serious cases. Hepatitis C can greatly damage the liver. Under a lawsuit settlement, the […]
Tags: News, Ap, Michigan, Detroit, Rick Snyder, Hepatitis C, Nation & World

Doctors Tried Transplants Using Diseased Organs. One Year Later, the Recipients Are Still Disease-Free

More than 90,000 people in the U.S. are waiting for a kidney transplant, and new research suggests an unusual approach may help cut down the list: using diseased kidneys. In a new study published in the journal Annals of Internal Medicine, researchers gave 10 willing people, who were in need of a kidney transplant, kidneys…
Tags: News, Medicine, Uncategorized, Kidney transplant, Organ Transplant, Johns Hopkins, Transplant, Annals of Internal Medicine, Hepatitis C, Healthytime, hepatitis-C organ transplant

Police accused of exaggerating risks of HIV to introduce spit guards

Force plans to issue guards to officers from January, saying people infected with blood-borne viruses use spitting as a ‘weapon’A police force has been accused of fearmongering and stigmatising sufferers of hepatitis C and HIV by playing up the risks of transmission of blood-borne viruses as a reason to introduce spit guards.Avon and Somerset police announced their plan to issue spit guards to all operational officers from January next year. “Each day we face being spat at, putting us at risk of...
Tags: Police, Society, UK News, Aids and HIV, Avon, Somerset, Hepatitis C, Stephen Cullen

Mongolia's liver cancer crisis: 'No other country has a problem like this' | Hannah Griffin

Cirrhosis and liver cancer cause 15% of all deaths in Mongolia. Now the government is waking up to the issue – and tackling the hepatitis that triggers it Danzan Purev beams as he shows members of a support group photos of his infant nephew on his iPhone. The 68-year-old geologist is charismatic and jokes with the others gathered in the room in Ulan Bator. But his mood changes as he begins to recount his long experience with hepatitis, a disease that has blighted his life.Purev was diagnosed wit...
Tags: Health, Cancer, Society, World news, Korea, Global development, Mongolia, Global Health, Hepatitis C, Hepatitis B, Hannah Griffin, Danzan Purev, Purev

Doctors Are Using Diseased Organs To Save Lives. Here’s How

For two long years, Tom Giangiulio jr., 58, was on the national waiting list for a heart transplant. He had cardiomyopathy, a condition that can weaken the heart muscle, and although he’d taken medication and had surgery to fix the problem, his doctors said there wasn’t much more they could do. He would have to…
Tags: News, Medicine, Uncategorized, Surgery, Kidney transplant, Penn Medicine, Transplant, Hepatitis C, Hep C, Innovation Health, Heart Transplant, Healthytime, Cure For Hepatitis C, Heart Transplant Surgery, Hepatitis C Cure, Kidney Transplant Donor

Gilead Makes Long-Awaited Splash With $12B Bet on Kite, Cell Therapy

Investors have been waiting for years for Gilead Sciences to make another big splash. This morning, it finally did, agreeing to buy Kite Pharma for close to $12 billion in a significant bet on the success of an emerging, cutting edge type of cancer immunotherapy known as CAR-T. Gilead (NASDAQ: GILD), of Foster City, CA, is paying $180 per share in cash for Santa Monica, CA-based Kite (NASDAQ: KITE), a 29 percent premium to the company’s $139.10 per share closing price on Friday and a deal...
Tags: Deals, Drugs, San Francisco, Trends, Novartis, Biotech, Lymphoma, Life Sciences, Clinical Trials, Gilead Sciences, Harvoni, Sovaldi, Kite, Gilead, Santa Monica CA, Hepatitis C

The Most Deadly Infectious Disease Rampant In Colorado’s Prison System

The Most Deadly Infectious Disease Rampant In Colorado’s Prison System The post The Most Deadly Infectious Disease Rampant In Colorado’s Prison System appeared first on Legal Reader.
Tags: Business, Lawsuit, Class, Legal, Prison, Colorado, Alcohol, System, Cure, Virus, Case, Program, Treatment, Aclu, Dead, Disease

Hepatitis C Is Spiking Among Young People

Cases of hepatitis C in the United States have nearly tripled within a five-year period, reaching a new 15-year high of around 34,000 new hepatitis C infections in 2015, federal health officials reported. Experts attribute the higher rates to more injection drug use during the ongoing opioid epidemic. The new report from the U.S. Centers…
Tags: News, Cdc, Uncategorized, Public Health, United States, Heroin, Hepatitis C, Opioids, Young Adults, Opioid, Opioid Epidemic, Hep C, hepatitis C treatment, Hepatitis C Vaccine, Injectable Drugs

Vertex Bags Concert’s Rival CF Drug For $160M, Plans Combo Studies

Concert Pharmaceuticals has been plugging away with an experimental cystic fibrosis drug that, if successful, might someday pose a threat to Vertex Pharmaceuticals. So rather than wait to find out, Vertex today paid $160 million in cash, up front, to bring the drug in house. Boston-based Vertex (NASDAQ: [[tickerVRTX]]) has acquired CTP-656, a CF drug currently in Phase 2 testing, from Concert (NASDAQ: CNCE). Vertex could pay Concert, of Lexington, MA, another $90 million in downstream pay...
Tags: Deals, Drugs, Boston, Trends, Abbvie, Cystic Fibrosis, Life Sciences, Clinical Trials, CRISPR Therapeutics, Vertex, CTP, Hepatitis C, Kalydeco, Concert Pharmaceuticals, Moderna Therapeutics, Vertex Pharmaceuticals

Dental Care May Have Exposed Vets to HIV, Hepatitis

After willfully failing to follow proper infection control procedures over the course of a year, a dentist who provided care to hundreds of veterans at Wisconsin’s Tomah Veterans Affairs Medical Center has put those he treated at potential risk for developing HIV and Hepatitis B and C. This latest development follows the center’s already tarnished The post Dental Care May Have Exposed Vets to HIV, Hepatitis appeared first on Legal Reader.
Tags: Hiv, Veterans, Wisconsin, Dentistry, News & Politics, Drugs & Medical Devices, Health & Medicine, Hepatitis C, Tomah Veterans Affairs Medical Center, Veteran's Affairs, Patient Safety

Trinity Health – Hepatitis C Lawsuit Settlement Pending

According to U.S. News, Trinity Health has reached, at least in principle, a hepatitis C lawsuit settlement that has been pending in North Dakota. The plaintiffs’ attorney, Behdad Sadeghi, indicated that the settlement involving 21 of the victims still needed to be finalized. Even so, attorneys for Trinity filed a motion to dismiss the lawsuitThe post Trinity Health – Hepatitis C Lawsuit Settlement Pending appeared first on Legal Reader.
Tags: Lawsuit, Cdc, North Dakota, Trinity, Medical Malpractice, Drugs & Medical Devices, Health & Medicine, Lawsuits & Litigation, Trinity Health, Hepatitis C, ManorCare

Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More

Quarterly biopharma earnings added a little heat to the already high summer temperatures. Amongst several companies to report this week, the biggest news came from Gilead Sciences (NASDAQ: GILD), whose hepatitis C drugs have become some of the top revenue producers in the industry. But the company said this week that sales of Sovaldi and Harvoni, which share a common ingredient, sofosbuvir, have slowed with fewer patients starting on the drugs and prices undercut by fierce competition from ...
Tags: Deals, Europe, Japan, New York, Trends, Indianapolis, Prostate Cancer, Cambridge, San Diego, Astrazeneca, Fda, National, Pfizer, Abbvie, Biotech, Microbiome

Hepatitis C Genotyping: Therapeutic Implications

The hepatitis C virus (HCV) is a RNA virus belonging to the Flaviviridae family which causes viral hepatitis, a systemic infection affecting predominantly the liver and causing its inflammation and resulting in impaired liver function. The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products. Infection with HCV may present as...
Tags: Health, Asia, China, India, South Africa, Middle East, Microbiology, World Health Organization, Geneva, South East Asia, North Africa, HCC, SVR, European Association, Hepatitis C

Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More

If you blinked, you probably missed something this week in biotech. The nation’s biggest annual cancer meeting took place in Chicago, while biotech’s trade group held its annual confab in San Francisco. In Boston, there were more twists for a closely watched Duchenne muscular dystrophy drug and a setback for a high-profile drug for multiple sclerosis. Plans for new incubators were announced in two different cities. We’ve got those stories, plus a spate of financings and deals, a legal feud,...
Tags: Google, Deals, New York, Jennifer Lawrence, Steve Jobs, Ipo, Boston, Massachusetts, Cancer, America, San Francisco, Trends, Merck, Joe Biden, Chicago, Multiple Sclerosis